DK2403512T3 - Sammensætninger af polymer myrcen - Google Patents

Sammensætninger af polymer myrcen Download PDF

Info

Publication number: DK2403512T3
Authority: DK; Denmark
Prior art keywords: myrc; compositions; polymer; polymer myrc
Prior art date: 2009-03-04

Application number

DK10710912.6T

Other languages

English (en)

Inventor

Shimon Amselem

Zadik Hazan

Original Assignee

Regenera Pharma Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2009-03-04

Filing date

2010-03-04

Publication date

2019-07-22

2010-03-04 Application filed by Regenera Pharma Ltd filed Critical Regenera Pharma Ltd

2019-07-22 Application granted granted Critical

2019-07-22 Publication of DK2403512T3 publication Critical patent/DK2403512T3/da

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/22—Anacardiaceae (Sumac family), e.g. smoketree, sumac or poison oak
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Natural Medicines & Medicinal Plants (AREA)
Alternative & Traditional Medicine (AREA)
Biotechnology (AREA)
Botany (AREA)
Medical Informatics (AREA)
Microbiology (AREA)
Mycology (AREA)
Epidemiology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Dermatology (AREA)
Heart & Thoracic Surgery (AREA)
Hematology (AREA)
Diabetes (AREA)
Immunology (AREA)
Vascular Medicine (AREA)
Cardiology (AREA)
Hospice & Palliative Care (AREA)
Urology & Nephrology (AREA)
Pulmonology (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Obesity (AREA)
Child & Adolescent Psychology (AREA)

DK10710912.6T 2009-03-04 2010-03-04 Sammensætninger af polymer myrcen DK2403512T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US15721609P	2009-03-04	2009-03-04
PCT/IL2010/000184 WO2010100651A2 (en)	2009-03-04	2010-03-04	Compositions of polymeric myrcene

Publications (1)

Publication Number	Publication Date
DK2403512T3 true DK2403512T3 (da)	2019-07-22

Family

ID=42536397

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK10710912.6T DK2403512T3 (da)	2009-03-04	2010-03-04	Sammensætninger af polymer myrcen

Country Status (15)

Country	Link
US (4)	US8722105B2 (da)
EP (2)	EP2403512B1 (da)
CN (2)	CN102413834B (da)
AU (1)	AU2010220057C1 (da)
BR (1)	BRPI1013222B8 (da)
CA (1)	CA2754565C (da)
DK (1)	DK2403512T3 (da)
EA (2)	EA201492273A1 (da)
ES (1)	ES2739033T3 (da)
HK (1)	HK1218710A1 (da)
HU (1)	HUE045444T2 (da)
IL (2)	IL214923A (da)
PL (1)	PL2403512T3 (da)
TR (1)	TR201911270T4 (da)
WO (1)	WO2010100651A2 (da)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN102413833B (zh)	2009-03-04	2017-02-08	瑞吉纳拉制药公司	乳香部分的治疗应用
CA2754565C (en)	2009-03-04	2020-12-29	Regenera Pharma Ltd.	Compositions of polymeric myrcene
EP2493461B9 (en) *	2009-10-28	2016-05-18	Regenera Pharma Ltd.	Polymeric monoterpenes for treating impaired neurological function
BR122019022461B1 (pt)	2010-09-07	2022-03-15	Regenera Pharma Ltd	Processo para preparar uma fração ácida isolada de goma mástique
US8979797B2 (en) *	2010-12-16	2015-03-17	Ams Research Corporation	High pressure delivery system and method for treating pelvic disorder using large molecule therapeutics
WO2013011511A1 (en)	2011-07-18	2013-01-24	Mor Research Applications Ltd.	A device for adjusting the intraocular pressure
CN102526163A (zh) *	2011-12-27	2012-07-04	浙江景岳堂药业有限公司	一种用于风痛灵中乳香和没药的提取方法
US20150246087A1 (en) *	2012-06-11	2015-09-03	Regenera Pharma Ltd.	Extracts and therapeutic uses thereof
US10053603B2 (en)	2014-04-02	2018-08-21	Kraton Polymers U.S. Llc	Block copolymers containing a copolymer myrcene block
US9458362B2 (en)	2014-04-02	2016-10-04	Kraton Polymers U.S. Llc	Adhesive compositions containing a block copolymer with polymyrcene
IL237621A0 (en) *	2015-03-08	2015-06-30	Regenera Pharma Ltd	Use of isolated fractions of the gum goddess to treat optic neuropathy
AU2016327286A1 (en)	2015-09-24	2018-04-12	Regenera Pharma Ltd.	Compositions comprising triterpenoids
JP7031867B2 (ja)	2015-09-24	2022-03-08	レジネラファーマリミテッド	トリテルペノイドを含む組成物
US10548917B2 (en) *	2016-05-23	2020-02-04	Kaeco Group Inc.	Supplement for the prevention and treatment of gastrointestinal distress in horses and other species
US11439676B2 (en)	2018-10-16	2022-09-13	Kaeco Group, Inc.	Method for prevention or treating gastrointestinal distress in humans using mastic gum compositions
BR112019004500A2 (pt) *	2016-09-08	2019-05-28	Regenera Pharma Ltd	composições compreendendo extratos ácidos de goma de mastique e utilizações das mesmas para o tratamento de neuropatias óticas
AU2017322653A1 (en) *	2016-09-08	2019-04-04	Regenera Pharma Ltd.	Compositions comprising triterpenoids and uses thereof for treating optic neuropathy
IT201700016726A1 (it) *	2017-02-15	2018-08-15	Phytoitalia Srl	Frazioni arricchite in terpeni esenti da politerpeni estratte dal mastice di chios, dispositivi cosmetici, nutraceutici e medici, e composizioni farmaceutiche che le contengono
WO2019170239A1 (en)	2018-03-08	2019-09-12	Phytoitalia Srl	Terpene enriched fractions free from polyterpenes extracted from chios mastic gum and cosmetic, nutraceutical, medical devices and pharmaceutical compositions containing them
CA3117018A1 (en) *	2018-11-01	2020-05-07	Yeditepe Universitesi	A medicine for treatment of psoriasis and production method thereof

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4374957A (en)	1981-10-29	1983-02-22	Michigan Molecular Institute	Triblock polymers of a monovinyl aromatic compound and myrcene
US4564718A (en)	1984-08-14	1986-01-14	The University Of Manchester Institute Of Science And Technology	Functionally terminated polymers from terpene monomers and their applications
US4713243A (en)	1986-06-16	1987-12-15	Johnson & Johnson Products, Inc.	Bioadhesive extruded film for intra-oral drug delivery and process
JPS63179908A (ja) *	1987-01-22	1988-07-23	Japan Synthetic Rubber Co Ltd	ミルセン重合体およびその製造方法
DE3820218A1 (de)	1988-06-14	1989-12-28	Osama L M Dr Med Dr Rer N Omer	Phytotherapeutikum zur behandlung von depressivem syndrom
US8178516B2 (en)	1992-06-30	2012-05-15	Sylvan Labs, LLC	Compositions and method for treatment of chronic inflammatory diseases
US5506406A (en)	1993-05-17	1996-04-09	Atomic Energy Corporation Of South Africa Ltd.	Method and apparatus for determining the concentration of a heavy element in a rock face
US5759569A (en)	1995-01-10	1998-06-02	The Procter & Gamble Company	Biodegradable articles made from certain trans-polymers and blends thereof with other biodegradable components
US5714007A (en)	1995-06-06	1998-02-03	David Sarnoff Research Center, Inc.	Apparatus for electrostatically depositing a medicament powder upon predefined regions of a substrate
GR950100243A (el)	1995-06-28	1997-02-28	�. ��- �. �� .�.�.	Χρησιμοποιηση της φυσικης μαστιχας χιου η του εξαγομενου εξ'αυτης φυσικου μαστιχελαιου η συνθετικων παραγωγων του για την παρασεκυη οδοντοκρεμας, οδοντικου διαλυματος, αποσμητικου στοματος, αντιηλιακων, προιοντων μαλλιων, καθως και καλλυντικων προιοντων.
JPH10130254A (ja) *	1996-11-01	1998-05-19	Jumoku Seiri Kinousei Butsushitsu Gijutsu Kenkyu Kumiai	ジヒドロクマリン系化合物およびエストロゲン作用剤
DE19646392A1 (de)	1996-11-11	1998-05-14	Lohmann Therapie Syst Lts	Zubereitung zur Anwendung in der Mundhöhle mit einer an der Schleimhaut haftklebenden, Pharmazeutika oder Kosmetika zur dosierten Abgabe enthaltenden Schicht
GR1003541B (el)	1999-05-11	2001-03-07		Αντιμικροβιακη και αντιμυκητιακη δραση του εξαγομενου απο τα κλαδια, φυλλα και καρπο της μαστιχας χιου -pistacia lentiscus var chia-, μαστιχελαιου, για χρηση σε καλλυντικες, φαρμακευτικες και παραφαρμακευτικεσς εφαρμογες καθως και στην παραγωγη οδοντοτσι
GR1003550B (el)	1999-09-22	2001-03-13		Σταθερο παρασκευασμα ισοεξυλοναφθαζαρινων με πεντα- και τετρα-κυκλικα τριτερπενια, συστατικα φυτικων ελαιορητινων και κομμεων
US6623728B2 (en)	2000-06-30	2003-09-23	Unilever Home & Personal Care Usa Division Of Conopco, Inc.	Cosmetic skin care compositions and containing gum mastic
US7056491B2 (en)	2000-11-08	2006-06-06	Wisconsin Alumni Research Foundation	Monoterpenes and sesquiterpenes as chemotherapeutic and radiation sensitizers and immunomodulators
GR1003868B (el) *	2001-02-06	2002-04-19	Lavipharm S.A.	Αξιολογηση των επουλωτικων, αντιοξειδωτικων και κυτταροστατικων ιδιοτητων της μαστιχας και των συστατικων της, και οι εφαρμογες τους
IL156976A0 (en)	2001-02-13	2004-02-08	Yissum Res Dev Co	Carotenoid-loaded liposomes
US6534548B1 (en)	2001-10-02	2003-03-18	Kimberly-Clark Worldwide, Inc.	Isoprenoid compositions for the inhibition of exoprotein production from gram positive bacteria
US20050238740A1 (en)	2002-05-01	2005-10-27	Spiros Fotinos	Use of mastic and its components for the control of microbial infections
JP2004083443A (ja)	2002-08-23	2004-03-18	Hideji Watanabe	マスティックを用いた歯周病予防・治療用組成物及び歯周病予防・治療方法
JP4426527B2 (ja)	2002-12-20	2010-03-03	エクソンモービル・ケミカル・パテンツ・インク	重合プロセス
JP4690195B2 (ja)	2002-12-20	2011-06-01	エクソンモービル・ケミカル・パテンツ・インク	新しい配列分布を有するポリマー
US20050074509A1 (en)	2003-10-02	2005-04-07	Data Medica Padova S.P.A.	Cancer treatment using natural plant products or essential oils extracted from some pistacia species or components
CA2548430A1 (en)	2003-12-08	2005-06-16	Kenneth John Falk	Plant materials extraction method
EP1721914B1 (en)	2004-03-04	2010-11-17	Riken	Isotactic 3,4-isoprene polymer
WO2005112967A2 (en) *	2004-05-19	2005-12-01	Balfour Marketing Corp.	Anticancer activity of chios mastic gum
EP1768742A4 (en)	2004-07-06	2007-10-17	Transpharma Medical Ltd	ADMINISTRATION SYSTEM FOR TRANSDERMAL IMMUNIZATION
AU2005274765B2 (en)	2004-07-23	2012-08-30	Arjil Pharmaceuticals Llc	Anti-hypersensitive inflammation and anti-allergy activities of Zingiber zerumbet (L.) Smith
US20090274778A1 (en)	2004-11-13	2009-11-05	Babish John G	Compositions Exhibiting Inhibition Of Cyclooxygenase-2
US20070036873A1 (en)	2005-07-27	2007-02-15	Shibnath Ghosal	Method of treatment or management of stress
US20070148187A1 (en)	2005-12-27	2007-06-28	Intact Enterprises, Inc.	Mastic gum composition for use as a dietary supplement in humans and animals
AR060847A1 (es)	2007-05-03	2008-07-16	Spannagel Lucia Antonia	Formulacion a base de calendula, aloe y centella.
CA2754565C (en)	2009-03-04	2020-12-29	Regenera Pharma Ltd.	Compositions of polymeric myrcene
CN102413833B (zh)	2009-03-04	2017-02-08	瑞吉纳拉制药公司	乳香部分的治疗应用

2010
- 2010-03-04 CA CA2754565A patent/CA2754565C/en active Active
- 2010-03-04 TR TR2019/11270T patent/TR201911270T4/tr unknown
- 2010-03-04 CN CN201080018570.3A patent/CN102413834B/zh not_active Expired - Fee Related
- 2010-03-04 AU AU2010220057A patent/AU2010220057C1/en not_active Ceased
- 2010-03-04 EA EA201492273A patent/EA201492273A1/ru unknown
- 2010-03-04 EP EP10710912.6A patent/EP2403512B1/en active Active
- 2010-03-04 ES ES10710912T patent/ES2739033T3/es active Active
- 2010-03-04 EA EA201190170A patent/EA021833B1/ru not_active IP Right Cessation
- 2010-03-04 BR BRPI1013222A patent/BRPI1013222B8/pt not_active IP Right Cessation
- 2010-03-04 US US13/254,380 patent/US8722105B2/en active Active
- 2010-03-04 HU HUE10710912A patent/HUE045444T2/hu unknown
- 2010-03-04 EP EP19158751.8A patent/EP3578191A1/en active Pending
- 2010-03-04 PL PL10710912T patent/PL2403512T3/pl unknown
- 2010-03-04 CN CN201510616984.0A patent/CN105147759A/zh active Pending
- 2010-03-04 WO PCT/IL2010/000184 patent/WO2010100651A2/en active Application Filing
- 2010-03-04 DK DK10710912.6T patent/DK2403512T3/da active
2011
- 2011-09-01 IL IL214923A patent/IL214923A/en active IP Right Grant
2014
- 2014-03-26 US US14/226,293 patent/US9655938B2/en active Active
2016
- 2016-06-10 HK HK16106667.1A patent/HK1218710A1/zh unknown
- 2016-09-26 IL IL248056A patent/IL248056B/en active IP Right Grant
2017
- 2017-04-13 US US15/486,964 patent/US10307449B2/en active Active
2019
- 2019-04-23 US US16/391,881 patent/US10806763B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
WO2010100651A4 (en)	2010-12-23
CN102413834B (zh)	2016-11-09
TR201911270T4 (tr)	2019-08-21
IL248056A0 (en)	2016-11-30
CA2754565A1 (en)	2010-09-10
US9655938B2 (en)	2017-05-23
US20120039992A1 (en)	2012-02-16
BRPI1013222B8 (pt)	2021-05-25
EA021833B1 (ru)	2015-09-30
CN102413834A (zh)	2012-04-11
US8722105B2 (en)	2014-05-13
ES2739033T3 (es)	2020-01-28
AU2010220057A1 (en)	2011-10-13
WO2010100651A3 (en)	2010-10-28
US10806763B2 (en)	2020-10-20
US20140294928A1 (en)	2014-10-02
PL2403512T3 (pl)	2019-10-31
EA201492273A1 (ru)	2015-04-30
WO2010100651A2 (en)	2010-09-10
EP2403512A2 (en)	2012-01-11
EP2403512B1 (en)	2019-05-15
IL214923A0 (en)	2011-11-30
CA2754565C (en)	2020-12-29
IL248056B (en)	2019-07-31
US20170252387A1 (en)	2017-09-07
US20190255132A1 (en)	2019-08-22
EA201190170A1 (ru)	2013-01-30
HUE045444T2 (hu)	2019-12-30
AU2010220057B2 (en)	2015-04-02
US10307449B2 (en)	2019-06-04
HK1218710A1 (zh)	2017-03-10
EP3578191A1 (en)	2019-12-11
IL214923A (en)	2016-10-31
CN105147759A (zh)	2015-12-16
BRPI1013222B1 (pt)	2021-03-16
BRPI1013222A2 (pt)	2017-09-26
AU2010220057C1 (en)	2015-10-29

Publication	Publication Date	Title
DK2403512T3 (da)	2019-07-22	Sammensætninger af polymer myrcen
EP2473555A4 (en)	2014-10-08	POLYMER COMPOSITIONS
DK3078664T3 (da)	2019-05-13	Antiparasitiske dihydroazol-sammensætninger
EP2488022A4 (en)	2014-02-19	Compositions
BR112012005237A2 (pt)	2016-03-15	utilização de composições ternárias
UY33161A (es)	2011-07-29	Composiciones plaguicidas
DOP2011000396A (es)	2012-02-15	Composiciones novedosas
DK2498756T3 (da)	2019-11-25	Tabletformuleringer af neratinibmaleat
BRPI1013588A2 (pt)	2016-04-19	composição
IT1400743B1 (it)	2013-07-02	Composizioni polimeriche
BRPI1015474A2 (pt)	2016-04-26	composição
EP2513226A4 (en)	2015-04-01	HALOGEN-FREE FLAME RETARDANT COMPOSITIONS
DK2633006T3 (da)	2019-08-19	Fremstilling af fornybart bio-destillat
BRPI1010690A2 (pt)	2016-03-15	composições
DK2358714T3 (da)	2012-08-20	Alkylcyclohexylethere af dihydrotetraazabenzoazulener
DK2111555T3 (da)	2013-09-02	Diagnosticering af præeklampsi
DK2459129T3 (da)	2019-10-07	Forbedringer af karstøtteanordninger
DK2260873T3 (da)	2019-09-16	Pcylering af proteiner
DK3284820T3 (da)	2020-12-07	Fremgangsmåde til behandling af pyropheophytin-holdige sammensætninger
DK2408446T3 (da)	2019-12-09	Anvendelse af farmaceutiske sammensætninger, der indeholder mesembrenon
DK2506840T3 (da)	2021-04-12	Anvendelser af hæmmere af hypoksi-fremkaldende faktorer
DK2393650T3 (da)	2014-08-04	Fremstilling af elastomerfilm
BRPI1007245A2 (pt)	2016-10-18	composição polimérica
BRPI1005318A2 (pt)	2016-02-10	composição
FR2948673B1 (fr)	2011-12-30	Compositions de resines pvc